Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Launching of EHealth Lebanon Mobile App. for MoPH Digital Services

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani launched EHealth Lebanon mobile App for the MOPH  digital services. This project is the product of collaboration between the Ministry of Public Health and Loubnaniyoun Association, knowing that the Ministry has not incurred any financial costs. The launching ceremony was attended by the head of the Lebanese Order of Physicians in Beirut Pr. Raymond Sayegh, the Syndicate of Private Hospitals President Suleiman Haroun, the President of the Syndicate of Nurseries in Lebanon Hana Joujou, representatives of Loubnaniyoun Association, Dr. Guy Hokayem, Mrs. Katia Mansour, the National E-health Programme Director Lina Abou Mrad and concerned parties.
 
Abou Mrad opened the launching ceremony by introducing the MOPH’s process of facilitating the administrative procedures back from 2000 to date. In this context, several projects were completed to end up with the digital services. She also mentioned the different strategic initiatives of the Ministry within “Health 2025” Plan, which are: digital complaint reporting, the electronic medical record (EMR), custom registration, Drug barcode system, the One stop Shop, and e-government services.
 
Mrs. Mrad delivered a technical presentation on EHealth Lebanon mobile application, during which she introduced the different digitized services that are available to all the citizens on the digital platform that was developed to this end.
 
Minister Hasbani noted that launching the digital services is considered as a new step in the service of the Lebanese citizen. The role of the Ministry of Public Health encompasses not only the medical services provision, but also the supervision and registration of the medical professions, drug warehouses and the companies that import them. Hasbani added that all the transactions are now electronically available.  
 
 “The implementation of the project will take a long time, since the administrative services will be provided in parallel with the electronic ones for the citizens to get used to the digital services,” noted Hasbani.

“This project aims at keeping up with the evolving human competences of the physicians and medical professions workers”, said Hasbani.
    ...
    155
    ...
ATC Name B/G Ingredients Dosage Form Price
B01AF01 XAVIRAN G Rivaroxaban - 15mg 15mg Tablet, film coated 952,208 L.L
B01AF01 VAROXA G Rivaroxaban - 15mg 15mg Tablet, film coated 1,343,843 L.L
B01AF01 RIXALTA 15 G Rivaroxaban - 15mg 15mg Tablet, film coated 1,164,664 L.L
B01AF01 RIBAVAN G Rivaroxaban - 15mg 15mg Tablet, film coated 1,343,843 L.L
B01AF01 XARELTO B Rivaroxaban - 15mg 15mg Tablet, film coated 4,440,862 L.L
B01AF01 RIBAVAN G Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 3,199,625 L.L
B01AF01 XARELTO B Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 4,045,168 L.L
B01AE07 DAXATRAN G Dabigatran etexilate (mesilate) - 150mg 150mg Capsule, hard 1,803,437 L.L
B01AE07 PRADAXA B Dabigatran etexilate (mesilate) - 150mg 150mg Capsule, hard 3,031,709 L.L
B01AE07 DAXATRAN G Dabigatran etexilate (mesilate) - 110mg 110mg Capsule, hard 1,803,437 L.L
B01AE07 PRADAXA B Dabigatran etexilate (mesilate) - 110mg 110mg Capsule, hard 3,205,064 L.L
B01AE07 PRADAXA B Dabigatran etexilate (mesilate) - 110mg 110mg Capsule, hard 1,603,204 L.L
B01AE07 DAXATRAN G Dabigatran etexilate (mesilate) - 75mg 75mg Capsule, hard 1,811,500 L.L
B01AE07 PRADAXA B Dabigatran etexilate (mesilate) - 75mg 75mg Capsule, hard 1,603,204 L.L
B01AE07 PRADAXA B Dabigatran etexilate (mesilate) - 75mg 75mg Capsule, hard 3,205,064 L.L
B01AD11 METALYSE BioTech Tenecteplase - 10,000IU 10,000IU Injectable powder for solution+diluent 74,851,424 L.L
B01AD02 ACTILYSE BioTech Alteplase - 50mg 50mg Injectable dry powder for solution+diluent 97,130,035 L.L
B01AC27 UPTRAVI B Selexipag - 1600mcg 1600mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1400mcg 1400mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1200mcg 1200mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 1000mcg 1000mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 800mcg 800mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 600mcg 600mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 400mcg 400mcg Tablet, film coated 275,097,581 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 613,462,617 L.L
B01AC27 UPTRAVI B Selexipag - 200mcg 200mcg Tablet, film coated 275,097,581 L.L
B01AC24 KLOTEGO G Ticagrelor - 60mg 60mg Tablet, film coated 2,598,096 L.L
B01AC24 KLOTEGO G Ticagrelor - 60mg 60mg Tablet, film coated 2,598,096 L.L
B01AC24 KLOTEGO G Ticagrelor - 90mg 90mg Tablet, film coated 2,598,096 L.L
B01AC24 KLOTEGO G Ticagrelor - 90mg 90mg Tablet, film coated 2,598,096 L.L
    ...
    155
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025